formally known as gpha

Same medicine. Same results.
Lower cost.

GPhA Recognizes February as American Heart Month

Contact: Steve Arnoff 202.249.7113

WASHINGTON, DC (February 19, 2016) — The Generic Pharmaceutical Association (GPhA) is pleased to recognize February as American Heart Month, and proud to note that generic cardiovascular drugs saved the U.S. health system $63 billion in 2014, according to data from the annual Generic Drug Savings in the U.S. report. This includes generic drugs for treating hypertension, cholesterol and other cardiovascular drugs.

“Safe, effective and more affordable generic drugs keep costs low for patients, enhance access and promote prescription adherence, particularly among the 85 million people living with cardiovascular disease in the United States,” said Chip Davis, President and CEO, GPhA. “Savings from generic drugs today help provide the headroom for spending on research, education and prevention of cardiovascular conditions and other diseases. Choosing generic drugs is a smart health decision patients can make now that could improve the rest of their lives.”

Visit the American Heart Association website for more information on American Heart Month:

About GPhA
GPhA represents the manufacturers and distributors of finished generic pharmaceuticals, manufacturers and distributors of bulk pharmaceutical chemicals, and suppliers of other goods and services to the generic industry. Generic pharmaceuticals fill 88 percent of the prescriptions dispensed in the U.S. but consume just 28 percent of the total drug spending. Additional information is available at Follow us on twitter: @gpha.